Skip to main content
Fig. 1 | Addiction Science & Clinical Practice

Fig. 1

From: Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations

Fig. 1

Study overview. Data from the source population, two National Drug Abuse Treatment Clinical Trials Network studies, is pooled to estimate the association between stimulant use and initiation of medication for opioid use disorder in the trials. Differences between trial participants and target populations are used to estimate the probability of trial participation. Inference is made in target populations by re-weighting trial participants to better match the characteristics of individuals in target populations

Back to article page

Addiction Science & Clinical Practice

ISSN: 1940-0640